RESUMO
One of the few and largest randomised controlled trials of point-of-care testing (PoCT) in general practice was conducted in Australia. This trial showed PoCT provided the same or better clinical effectiveness than central laboratory testing for HbA1c, urinary albumin/creatinine ratio, cholesterol and triglyceride measurements but not for the international normalised ratio (INR) or high-density lipoprotein (HDL) cholesterol. For most tests, however, testing in the central laboratory was more cost-effective than PoCT. One factor that contributed to the higher cost of PoCT was the considerable amount of resources devoted to training and monitoring the PoCT operators throughout the trial, many of whom were in remote locations.
Assuntos
Troca de Informação em Saúde/tendências , Internet , Testes Imediatos/tendências , Atenção Primária à Saúde/métodos , Austrália , Humanos , Atenção Primária à Saúde/tendências , Serviços de Saúde RuralRESUMO
Specificity counts: A template-based approach to protease inhibitors is presented using a core macrocycle that presents a generic ß-strand template for binding to protease active sites. This is then specifically functionalized at P2 , and the C and Nâ termini to give inhibitors of calpainâ 2, 20S proteasome, and HIV-1 protease.